On Monday, Cellebrite DI Ltd (NASDAQ: CLBT) was -4.47% drop from the session before settling in for the closing price of $12.98. A 52-week range for CLBT has been $6.36 – $14.11.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Technology sector has jumped its sales by 18.79% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 52.09%. With a float of $61.29 million, this company’s outstanding shares have now reached $203.23 million.
In an organization with 1008 employees, it is important to assess its efficiency.
Cellebrite DI Ltd (CLBT) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Cellebrite DI Ltd stocks. The insider ownership of Cellebrite DI Ltd is 70.15%, while institutional ownership is 30.83%.
Cellebrite DI Ltd (CLBT) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 3/31/2024, it has been observed that the corporation posted 0.05 earnings per share (EPS) during the time that was better than consensus figure (set at 0.02) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 52.09% per share during the next fiscal year.
Cellebrite DI Ltd (NASDAQ: CLBT) Trading Performance Indicators
You can see what Cellebrite DI Ltd (CLBT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.55. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.41. Likewise, its price to free cash flow for the trailing twelve months is 27.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.58, a number that is poised to hit 0.04 in the next quarter and is forecasted to reach 0.25 in one year’s time.
Technical Analysis of Cellebrite DI Ltd (CLBT)
Let’s dig in a bit further. During the last 5-days, its volume was 1.04 million. That was inferior than the volume of 1.07 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 30.87%. Additionally, its Average True Range was 0.51.
During the past 100 days, Cellebrite DI Ltd’s (CLBT) raw stochastic average was set at 55.76%, which indicates a significant increase from 22.62% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.98% in the past 14 days, which was higher than the 36.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.06, while its 200-day Moving Average is $10.22. However, in the short run, Cellebrite DI Ltd’s stock first resistance to watch stands at $12.72. Second resistance stands at $13.05. The third major resistance level sits at $13.46. If the price goes on to break the first support level at $11.99, it is likely to go to the next support level at $11.58. The third support level lies at $11.25 if the price breaches the second support level.
Cellebrite DI Ltd (NASDAQ: CLBT) Key Stats
There are 205,932K outstanding shares of the company, which has a market capitalization of 2.55 billion. As of now, sales total 325,110 K while income totals -81,100 K. Its latest quarter income was 89,580 K while its last quarter net income were -71,370 K.
